Primo Biotechnology 普瑞默生技

Primo Biotechnology 普瑞默生技 is a radiopharmaceutical company based in Taiwan. Founded in 2023 by Prof. Ya-Yao Huang and Dr. Joe Yeh, the company aims to advance precision healthcare through molecular imaging in Taiwan. With a wealth of experience in radiopharmaceutical discovery and development, especially in clinical introduction and IND submission of new radiopharmaceuticals, Primo is positioned as a key player in the biotechnology and pharmaceutical industries. The company prides itself in boasting multidisciplinary expertise in automating machinery, animal models, radiopharmaceutical development, and AI-based medical imaging. In June 12, 2023, Primo successfully secured a $4.00M Seed Round investment, signaling great potential and attracting the attention of venture capital firms in the industry.